Red Flags Detected
- Material Weakness (new) — Company identified multiple material weaknesses in internal controls including inadequate accounting policies, IT access issues, and communication failures affecting financial reporting reliability.
Shuttle Pharma pivots to AI drug discovery, winds down trials, discloses control weaknesses
Filed May 15, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 8, 2025 · ~2 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade SHPH commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 1, 2026 3:57 PM